NCT06840834
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06840834
Title Evaluating Ivonescimab As a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy (Bi-MAPS)
Acronym Bi-MAPS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Intergroupe Francophone de Cancerologie Thoracique
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Besançon - CHU RECRUITING Besançon France Details
Brest - CHU RECRUITING Brest France Details
Caen - CHU RECRUITING Caen France Details
Clermont-Ferrand - Centre Jean Perrin RECRUITING Clermont-Ferrand France Details
Créteil - CHI RECRUITING Créteil France Details
Grenoble - CHU RECRUITING Grenoble France Details
Le Mans - CHG RECRUITING Le Mans France Details
Lille - CHU RECRUITING Lille France Details
Marseille - APHM RECRUITING Marseille France Details
Montpellier - CHU RECRUITING Montpellier France Details
Mulhouse - GHRMSA RECRUITING Mulhouse France Details
Nantes - Hôpital Laennec RECRUITING Nantes France Details
Paris - Bichat RECRUITING Paris France Details
Bordeaux - CHU RECRUITING Pessac France Details
Lyon - HCL RECRUITING Pierre-Bénite France Details
Strasbourg - Nouvel Hôpital Civil RECRUITING Strasbourg France Details
Toulon - CHI RECRUITING Toulon France Details
Toulouse - CHU RECRUITING Toulouse France Details
Tours - CHU RECRUITING Tours France Details
Metz - Hôpital Robert Schuman RECRUITING Vantoux France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field